SHARE THIS VIDEO —
New research using mRNA vaccines targets rare cancers
Founder of the Medulloblastoma Initiative, Fernando Goldsztein, discusses the new MBI-funded research on experimental mRNA vaccines to treat cancer.
we and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. by using the site, you consent to these cookies. for more information on cookies including how to manage your consent visit our cookie policy.